Vascular Diseases

The supplied material supports heterogeneous causes rather than a single aetiology. Inherited cardiovascular disorders can involve vascular disorders, and genetic testing is described as relevant to their management. The literature also links vascular disease processes to oxidative stress and endothelial dysfunction, and to metabolic or microvascular complications in diabetes.

A key mechanism described is endothelial dysfunction driven by oxidative stress. Reactive oxygen species can reduce nitric oxide bioavailability, promote inflammation, and impair mitochondrial function, disrupting endothelial integrity and vascular function. The literature also notes roles for altered vascular metabolism, microvascular injury, and exosome-associated transfer of disease-related proteins in some vascular/neurological disorders.

The grounding supports vascular disease risk being increased by inherited cardiovascular disease predisposition and by vascular risk factors in mid-life. Diabetes-related microvascular disease is also implicated, and the literature specifically refers to targeting risk factors of vascular disease as a prevention strategy for vascular depression. No broader risk-factor list is supported by the supplied material.

Management is described at the modality and drug-class level rather than as a single uniform treatment. The literature supports genetic testing in inherited cardiovascular and vascular disorders, and treatment approaches that target vascular risk factors. It also mentions glucose-lowering incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, in the context of microvascular complications, and notes that prevention strategies may focus on reducing vascular risk and addressing endothelial dysfunction.